MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Ataxia: Clinical features"

  • 2022 International Congress

    COVID-19 encephalitis with anti-mGluR1 antibody-positive cerebellar ataxia

    F. Cheng, K. Tang, X. Wang (Kingston upon Hull, United Kingdom)

    Objective: To describe a unique case of anti-metabotropic glutamate receptor 1 (mGluR1) antibody (Ab)-mediated cerebellar ataxia post-COVID-19 encephalitis. Background: Cerebellar syndrome is increasingly recognised in…
  • 2022 International Congress

    Spinocerebellar ataxia 21 and phenotypic variability within a family

    M. Hull, M. Parnes, J. Jankovic (Houston, USA)

    Objective: We describe four patients within a family who presented to our movement disorders centers for evaluation of various symptoms including unsteady gait, tremor, and…
  • 2022 International Congress

    Japanese cases of Sez6l2 autoimmunity

    M. Abe, H. Yaguchi, A. Kudo, A. Nagai, S. Shirai, I. Iwata, M. Matsushima, A. Kimura, T. Shimohata, I. Yabe (Sapporo-shi, Japan)

    Objective: We aimed to establish a method for measuring anti-Sez6l2 antibody and to clarify how many patients with anti-Sez6l2 antibody-associated cerebellar ataxia (CA) exist in…
  • 2022 International Congress

    Clinical, imaging and genetic characteristics from an Indian ARSACS cohort

    A. Cherian, K P. Divya, B. Thomas (Thiruvananthapuram, India)

    Objective: Provide insight into SACS mutations in India, by targeted gene panel of a suspected cohort. Background: Autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), caused…
  • 2022 International Congress

    Volumetric analysis of the Corpus Callosum in Hereditary Cerebellar Ataxia

    A. Adarmes Gomez, M. Reina, M. Grothe, M. Labrador-Espinosa, S. Jesus, D. Garcia, L. Muñoz-Delgado, F. Carrillo-Garcia, P. Mir (Sevilla, Spain)

    Objective: To analyze corpus callosum (CC) volumes on MRI in patients under follow-up for confirmed or suspected hereditary cerebellar ataxia Background: It is recognized that…
  • 2022 International Congress

    CerebNet: Deep learning cerebellar subsegmentation for fast and reliable atrophy quantification

    J. Faber, D. Kuegler, E. Bahrami, L. Heinz, D. Timmann, T. Ernst, K. Deike-Hofmann, B. Vande Warrenburg, G. Oz, J. van Gaalen, J. Joers, K. Reetz, T. Klockgether, M. Reuter (Bonn, Germany)

    Objective: Establish a fast and reliable automatic tool for cerebellar subsegmentation. Background: Quantifying the volume of the cerebellum and its lobes is of profound interest…
  • 2022 International Congress

    A bitter syndrome as a cause of refractory movement disorders

    DD. García-Meléndez, F. Muñoz Escudero, MI. Morales-Casado, P. Lobato Casado, AM. Diezma Martín, G. Tabar Comellas, N. Sánchez Cano, B. Canovas Gaillemin, N. López Ariztegui (Toledo, Spain)

    Objective: Submit a case of GLUT-1 deficiency for consideration in the differential diagnosis of movement disorders and refractory epilepsies because early treatment will prevent progressive…
  • 2022 International Congress

    Gait ataxia and Autonomic dysfunction as early signs of Creutzfeldt-Jakob Disease: A Case Report

    S. Zaheer, E. Urrea-Mendoza, V. Veerappan (Greenville, USA)

    Objective: To highlight unusual early presenting symptoms of Sporadic Creutzfeldt-Jakob Disease (sCJD). Background: Prion diseases, a group of rare and fatal diseases caused by an…
  • 2022 International Congress

    Two Different Clinical Presentations in SYNE1 Ataxia in Turkey

    Y. Secil, A. Subasioglu (İzmir, Turkey)

    Objective: SYNE1 (Spectrin repeat-containing nuclear envelope protein 1) gene mutation, first diagnosed in French Canadians in 2007, is now reported from many regions around the…
  • 2022 International Congress

    Cerebellar and other motor symptoms in Huntington’s Disease: A multiple scale correlation study

    D. López-Mena, H. Martinez-Hernandez, J. Arista-Ramírez (Ciudad de Mexico, Mexico)

    Objective: To describe the cerebellar symptoms and other accompanying movement disorders in Huntington's Disease (HD). Background: HD is a pathological entity whose etiological substrate is…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 31
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley